➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Moodys
Express Scripts
Baxter
AstraZeneca

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

SCOPOLAMINE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Scopolamine patents expire, and when can generic versions of Scopolamine launch?

Scopolamine is a drug marketed by Mylan Technologies, Padagis Us, and Riconpharma Llc. and is included in three NDAs.

The generic ingredient in SCOPOLAMINE is scopolamine. There are twenty-one drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the scopolamine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Scopolamine

A generic version of SCOPOLAMINE was approved as scopolamine by PADAGIS US on January 30th, 2015.

  Try it Free

Drug patent expirations by year for SCOPOLAMINE
Drug Prices for SCOPOLAMINE

See drug prices for SCOPOLAMINE

Recent Clinical Trials for SCOPOLAMINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
EMSPhase 2
Dartmouth-Hitchcock Medical CenterPhase 1
Defender Pharmaceuticals, Inc.Phase 3

See all SCOPOLAMINE clinical trials

Pharmacology for SCOPOLAMINE
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists

US Patents and Regulatory Information for SCOPOLAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Technologies SCOPOLAMINE scopolamine SYSTEM;TRANSDERMAL 203753-001 Jun 19, 2019 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Padagis Us SCOPOLAMINE scopolamine SYSTEM;TRANSDERMAL 078830-001 Jan 30, 2015 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Riconpharma Llc SCOPOLAMINE scopolamine SYSTEM;TRANSDERMAL 212342-001 Nov 24, 2020 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Moodys
Express Scripts
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.